Title: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the
treatment of chronic hepatitis C: the real-world data in China
Version: 2 Date: 01 Nov 2023
Reviewer:  Chun-Ming Hong
Reviewer's report:
The revised manuscript improved much.
I have two suggestions: firstly, the format in Discussion should be uniformed. Secondly, in Line
251, "Bedsides" should be  "Besides".
Title: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the
treatment of chronic hepatitis C: the real-world data in China
Version: 2 Date: 01 Nov 2023
Reviewer:  Chun-Ming Hong
Reviewer's report:
The revised manuscript improved much.
I have two suggestions: firstly, the format in Discussion should be uniformed. Secondly, in Line
251, "Bedsides" should be  "Besides".
Please review this paper.
user
Title: Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the
treatment of chronic hepatitis C: the real-world data in China
Version: 2 Date: 01 Nov 2023
Reviewer:  Chun-Ming Hong
Reviewer's report:
The revised manuscript improved much.
I have two suggestions: firstly, the format in Discussion should be uniformed. Secondly, in Line
251, "Bedsides" should be  "Besides".
assistant